Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Syra HealthSYRA +4.44%13 Equity-to-Asset is 0.69 as of Jun. 2026, which is 5% above its 10-year median of 0.66. GuruFocus rates SYRA with a GF Score™ of 13/100 and a GF Value™ of $0.24 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Syra Health ranks better than 73.51% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Syra Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $2.63 Mil. Syra Health's Total Assets for the quarter that ended in Jun. 2026 was $3.83 Mil.
Therefore, Syra Health's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.69.
The historical rank and industry rank for Syra Health's Equity-to-Asset or its related term are showing as below:
SYRA'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.33 Med: 0.66 Max: 0.82
Current: 0.69
During the past 6 years, the highest Equity to Asset Ratio of Syra Health was 0.82. The lowest was -1.33. And the median was 0.66.
SYRA's Equity-to-Asset is ranked better than 73.51% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs SYRA: 0.69
Syra Health (OTCPK:SYRA) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Syra Health Equity-to-Asset Related Terms
Syra Health Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Syra Health's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SYRA vs AMS, ADIA, BMGL: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Syra Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syra Health Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Syra Health's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Syra Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syra Health (SYRA) has a Equity-to-Asset of 0.69 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Syra Health and its competitors. This is near median its historical median of 0.66. According to the industry distribution chart, Syra Health ranks #182 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 26.5%.
Is Syra Health's Equity-to-Asset too high?
Syra Health's current Equity-to-Asset of 0.69 is near median its 10-year median of 0.66. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Syra Health's value of 0.69 is 40.8% above this industry median. Based on the distribution chart, Syra Health ranks #182 out of 687 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Syra Health has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's Equity-to-Asset compare to AMS and ADIA?
According to the Healthcare Providers & Services industry distribution chart, Syra Health ranks #182 out of 687 companies for Equity-to-Asset. This puts Syra Health in the upper half of its industry. The industry median Equity-to-Asset is 0.49. Syra Health's value of 0.69 is 40.8% above this benchmark. While the company's 10-year median is 0.66 vs. the industry median of 0.49, Syra Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syra Health's current Equity-to-Asset of 0.69 is 40.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Syra Health and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syra Health's current Equity-to-Asset is 0.69, which is near median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.24, compared to a current price of $0.94 — trading 291.7% above its estimated fair value. The current Equity-to-Asset is 0.69, which is near median its 10-year median of 0.66 and 40.8% above the Healthcare Providers & Services industry median of 0.49. Syra Health's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Syra Health (SYRA), the current Equity-to-Asset is 0.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syra Health (SYRA) Overvalued in 2026?
Based on GuruFocus' analysis, Syra Health stock appears to be overvalued.
The current stock price of $0.94 is trading 291.7% above its estimated GF Value™ of $0.24.
GuruFocus considers Syra Health to be Significantly Overvalued.
Key valuation signals for SYRA:
Equity-to-Asset: 0.69 (near median its 10-year median of 0.66)
GF Value™: $0.24 vs. price of $0.94 (291.7% above fair value)
Industry Position: 40.8% above the Healthcare Providers & Services median (#182 of 687)
No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
13GF Score
Get the complete analysis for SYRA
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYRA has been successfully added to your 
